tiprankstipranks
Trending News
More News >
NeonMind Biosciences Inc (TSE:LCR)
:LCR
Canadian Market

NeonMind Biosciences Inc (LCR) Income Statement

Compare
12 Followers

NeonMind Biosciences Inc Income Statement

Last quarter (Q2 2024), NeonMind Biosciences Inc's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, NeonMind Biosciences Inc's net income was C$-276.01K. See NeonMind Biosciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Dec 22Dec 21Dec 20
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 415.80K
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 415.55K
Operating Expenses
-C$ 1.75MC$ 7.78MC$ 1.06M
Depreciation and Amortization
-C$ 1.13KC$ 689.00C$ 0.00
EBITDA
-C$ -1.75MC$ -7.83MC$ -1.06M
Operating Income
-C$ -1.75MC$ -7.83MC$ -1.06M
Other Income/Expenses
-C$ -3.47KC$ 1.13MC$ -971.56K
Pretax Income
-C$ -2.03MC$ -6.68MC$ -2.17M
Net Income
-C$ -2.03MC$ -7.21MC$ -2.68M
Per Share Metrics
Basic EPS
C$ -0.08C$ -1.80C$ -7.33C$ -2.86
Diluted EPS
C$ -0.08C$ -1.80C$ -7.33C$ -2.86
Weighted Average Shares Outstanding
45.07M 1.13M 983.30K 936.92K
Weighted Average Shares Outstanding (Diluted)
45.07M 1.13M 983.30K 936.92K
Currency in CAD

NeonMind Biosciences Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis